1250-95-9

1250-95-9 is a lipid of Sterol Lipids (ST) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 303 references associated with 1250-95-9 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 1250-95-9

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1250-95-9

MeSH term MeSH ID Detail
Hyperlipoproteinemia Type III D006952 4 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Total 2

NCBI Entrez Crosslinks

All references with 1250-95-9

Download all related citations
Per page 10 20 50 100 | Total 60
Authors Title Published Journal PubMed Link
pmid:
Levin W et al. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides. 1983 Arch. Biochem. Biophys. pmid:6401984
Li QT and Das NP Comparison of the effects of cholesterol and oxysterols on phospholipid bilayer microheterogeneity: a study of fluorescence lifetime distributions. 1994 Arch. Biochem. Biophys. pmid:7986094
Deckert V et al. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. 1998 Arterioscler. Thromb. Vasc. Biol. pmid:9672065
Higley NA et al. Comparative atherogenic effects of cholesterol and cholesterol oxides. 1986 Atherosclerosis pmid:3801085
Zhou Q et al. An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells. 2000 Atherosclerosis pmid:10704631
Baranowski A et al. Connective tissue responses to oxysterols. 1982 Atherosclerosis pmid:7066074
Chang JY et al. Establishment of two morphologically distinct PC12 cell lines resistant to 25-OH-cholesterol toxicity. 1997 Biochem. Biophys. Res. Commun. pmid:9344846
Watabe T et al. Epoxidation of cholesterol by hepatic microsomal lipid hydroperoxides. 1982 Biochem. Biophys. Res. Commun. pmid:7150318
Raaphorst GP et al. Effect of cholesterol alpha and beta epoxides on cell killing and transformation. 1987 Biochem. Pharmacol. pmid:3606646
Moody DE et al. Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes. 1991 Biochem. Pharmacol. pmid:2043152
Watabe T et al. A mechanism for epoxidation of cholesterol by hepatic microsomal lipid hydroperoxides. 1984 Biochim. Biophys. Acta pmid:6466699
Raicht RF and Cohen BI Sterol metabolism in the rat. Effect of cholesterol and cholesterol-alpha-epoxide on sterol metabolism in rats fed liquid diets. 1981 Biochim. Biophys. Acta pmid:7326255
Sevanian A et al. Lipid epoxide hydrolase in rat lung preparations. 1980 Biochim. Biophys. Acta pmid:7407199
Morisseau C Role of epoxide hydrolases in lipid metabolism. 2013 Biochimie pmid:22722082
Poirot M and Silvente-Poirot S Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer. 2013 Biochimie pmid:22613256
Ryan L et al. The role of the mitochondria in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta,6beta-epoxide. 2005 Br. J. Nutr. pmid:16197575
Küçük O et al. Increased plasma level of cholesterol-5 beta,6 beta-epoxide in endometrial cancer patients. 1994 Oct-Nov Cancer Epidemiol. Biomarkers Prev. pmid:7827587
Gruenke LD et al. Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. 1987 Cancer Res. pmid:3652048
Wrensch MR et al. Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease. 1989 Cancer Res. pmid:2702658